Friday, July 10, 2026

Drug profile · INN

oxymetholone

oxymetholone (ANADROL-50) is a androgen receptor agonist. Route of administration: oral. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — oxymetholone
US status
approved
Class
Route
ORAL
Patents
0
Programs
0
Data quality
0.84

Quick answer

oxymetholone (ANADROL-50) is a androgen receptor agonist. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN oxymetholone
Brand ANADROL-50
Mechanism Androgen Receptor agonist
Target Androgen receptor
Route ORAL
Formulation TABLET

Mechanism of action

Androgen Receptor agonist

Primary target: Androgen receptor

Approval history

Authority Status Date
FDA approved

Related & competitor drugs

  1. bicalutamide Androgen Receptor antagonist
  2. danazol Progesterone receptor agonist
  3. nandrolone decanoate Androgen Receptor agonist
  4. testosterone Genito-urinary system and sex hormones (G03)
  5. testosterone cypionate Androgen Receptor agonist
  6. apalutamide Antineoplastic and immunomodulating agents (L02)

Frequently asked questions

What is oxymetholone?

oxymetholone (ANADROL-50) is a androgen receptor agonist. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for oxymetholone?

ANADROL-50 is a marketed brand name for oxymetholone. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of oxymetholone?

oxymetholone has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.